Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVL | SUPN | TSHA | ||
| Company | Prevail Therapeutics Inc | Supernus Pharm | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.05 | 36.30 | 2.03 | ||
| High | 23.13 | 36.53 | 2.20 | ||
| Low | 22.97 | 35.53 | 1.98 | ||
| Last | 23.00 | 35.82 | 2.18 | ||
| Change | -0.02 | -0.30 | +0.17 | ||
| % Change | -0.09% | -0.83% | +8.46% | ||
| Volume | 2,619,900 | 231,900 | 5,278,200 | ||
| 20-Day Average Volume | 721,915 | 422,420 | 6,897,875 | ||
| Previous Close | 23.02 | 36.12 | 2.01 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.05 | 35.61 | 1.85 | ||
| 20-Day Raw Stochastic | 40.00% | 40.24% | 68.75% | ||
| 20-Day Relative Strength | 81.56% | 55.62% | 54.81% | ||
| Weighted Alpha | -11.96 | +32.45 | -20.71 | ||
| Today's Opinion | 72% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 72% Buy | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 24% Buy | 88% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.13% since 01/13/21 | -1.00% since 11/14/24 | -3.96% since 11/14/24 | ||
| Low | 22.85 on 01/15/21 | 34.86 on 11/18/24 | 1.94 on 11/15/24 | ||
| High | 23.17 on 01/14/21 | 36.53 on 11/21/24 | 2.34 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -0.39% since 12/21/20 | +6.39% since 10/21/24 | +7.92% since 10/21/24 | ||
| Low | 22.80 on 01/04/21 | 33.27 on 10/22/24 | 1.19 on 11/05/24 | ||
| High | 23.30 on 01/13/21 | 39.37 on 11/05/24 | 2.63 on 11/14/24 | ||
| 3-Month | |||||
| %Chg | +130.00% since 10/21/20 | +3.26% since 08/21/24 | -3.54% since 08/21/24 | ||
| Low | 9.21 on 10/30/20 | 29.50 on 09/11/24 | 1.19 on 11/05/24 | ||
| High | 23.35 on 12/17/20 | 39.37 on 11/05/24 | 2.63 on 11/14/24 | ||
| 6-Month | |||||
| %Chg | +47.25% since 07/21/20 | +27.70% since 05/21/24 | -24.57% since 05/21/24 | ||
| Low | 9.21 on 10/30/20 | 25.53 on 06/14/24 | 1.19 on 11/05/24 | ||
| High | 23.35 on 12/17/20 | 39.37 on 11/05/24 | 4.32 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 787,658 | 1,977,945 | 446,776 | ||
| Shares Outstanding, K | 34,246 | 55,219 | 204,943 | ||
| Annual Sales | 0 | 607,520,000 | 15,450,000 | ||
| Annual Net Income | -63,190,000 | 1,320,000 | -111,570,000 | ||
| Last Quarter Sales | N/A | 175,690,000 | 1,790,000 | ||
| Last Quarter Net Income | N/A | 38,500,000 | -25,520,000 | ||
| 60-Month Beta | 1.59 | 0.86 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.06 on 11/04/24 | -0.09 on 11/13/24 | ||
| Latest Earnings Date | 11/17/20 | 11/04/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.16 | 28.71 | ||